Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Contract Biomanufacturing Services Global Market - Forecast to 2027


Published on has announced the addition of “Contract Biomanufacturing Services Global Market - Forecast to 2027” research report to their offering. See more at -

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Contract Biomanufacturing Services Global Market - Forecast to 2027

  1. 1. Category : Biotechnology All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. Introduction to Report  Launch Date: December 19, 2018  Number of Pages: 204  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 4,950 Price For Site User License: USD 6,750 Price For Global User License: USD 9,000 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. About the Report The contract biomanufacturing global market is expected to grow at double digit CAGR to reach $48.8 billion by 2027. Biomanufacturing is a widely used term to describe the manufacture of biologic molecules for various stages of drug development right from pre-clinical stage to commercial supply. The biologic drug manufacturing is a complex process involving huge capital and sound technical expertise.
  4. 4. Key Highlights: Contract manufacturing organizations, particularly for R&D and clinical trials, are making product manufacture, more efficient and often less costly. In addition to that, the use of single-use bioreactors is effectively reducing the manufacture facility cost. This option is more viable for smaller and low-funded companies for their in-house candidate product manufacturing needs, whereby, the companies can avoid $50-$150 million facility costs for construction of fixed, dedicated stainless steel bioreactor-based bioprocessing systems and outsource their manufacturing requirements to CMOs which use single- use facilities which typically cost $25-$40 million for commercial manufacture. There is a continued growth of the biopharmaceutical market which is expected to nearly double in the next 10 years.
  5. 5. Key Highlights: Continues.. This will be a result of continued new product approvals, expansion of indications for current products which include less-developed countries becoming more affluent and increased drug demand of the aging population in the U.S. and other major pharmaceutical markets. Many blockbuster drugs losing their exclusivity are also giving room for many biosimilar (and bio-betters) companies to enter into the world’s biopharmaceuticals market subsequently attracting many CROs, CDMOs, and CMOs to enter into the picture. Hence, there is every reason to assume that future growth in biopharmaceutical outsourcing will continue at a minimum of 14% in western countries to about 18% in Asian countries.
  6. 6. Key Highlights: Continues.. The global bio-manufacturing outsourcing market is driven by factors such as globalization of bio- manufacturing facilities, increased funding from private venture capitals and government organizations, increasing outsourcing budgets and the emergence of latest technologies such as single-use bioreactors. An example of such investment includes WuXi Biologics, a contract development and manufacturing organization invested $240 million in a 25-acre site which is located in Shijiazhuang for the development of labs, as well as clinical manufacturing capabilities with a 5,000L bioreactor and 48,000L bioreactor for commercial manufacturing. There are restraints and threats as well which could potentially hamper the biomanufacturing outsourcing market.
  7. 7. Report Coverage: 1. Contract Biomanufacturing Global Market 2. Executive Summary 3. Market Analysis 4. Contract Biomanufacturing Services 5. Company Profiles For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  8. 8. Company Coverage: (Partial List) 1. Abzena Plc 2. Albany Molecular Research, Inc 3. Asahi Glass Co. Ltd. 4. Boehringer Ingelheim 5. Catalent Inc. 6. Charles River Laboratories 7. Fujifilm Diosynth Biotechnologies 8. Horizon Discovery Group, Plc 9. Jhl Biotech Inc. 10. Lonza Group 11. Merck Kgaa For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  9. 9. Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ For regular industry updates subscribe to our newsletter at: newsletter
  10. 10. How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: About Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Mr. Sudeep Chakravarty Email : Phone: +1-302-703-9904 (USA) +91-8762746600 (India)